These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 37335426)

  • 1. Polymeric nanoparticles for DNA vaccine-based cancer immunotherapy: a review.
    Danaeifar M; Negahdari B; Eslam HM; Zare H; Ghanaat M; Koushali SS; Malekshahi ZV
    Biotechnol Lett; 2023 Sep; 45(9):1053-1072. PubMed ID: 37335426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation.
    Rahimian S; Fransen MF; Kleinovink JW; Christensen JR; Amidi M; Hennink WE; Ossendorp F
    J Control Release; 2015 Apr; 203():16-22. PubMed ID: 25660830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
    Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
    Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigen.
    Hashemi Goradel N; Nemati M; Bakhshandeh A; Arashkia A; Negahdari B
    Int Immunopharmacol; 2023 Apr; 117():109887. PubMed ID: 36841155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quest for nanoparticle-powered vaccines in cancer immunotherapy.
    Sun Z; Zhao H; Ma L; Shi Y; Ji M; Sun X; Ma D; Zhou W; Huang T; Zhang D
    J Nanobiotechnology; 2024 Feb; 22(1):61. PubMed ID: 38355548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(lactic acid)-based particulate systems are promising tools for immune modulation.
    Peres C; Matos AI; Conniot J; Sainz V; Zupančič E; Silva JM; Graça L; Sá Gaspar R; Préat V; Florindo HF
    Acta Biomater; 2017 Jan; 48():41-57. PubMed ID: 27826003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases.
    Bolhassani A; Javanzad S; Saleh T; Hashemi M; Aghasadeghi MR; Sadat SM
    Hum Vaccin Immunother; 2014; 10(2):321-32. PubMed ID: 24128651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of nanotechnology in enhancing immunotherapy for cancer treatment: current effects and perspective.
    Li Y; Ayala-Orozco C; Rauta PR; Krishnan S
    Nanoscale; 2019 Oct; 11(37):17157-17178. PubMed ID: 31531445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Materials engineering strategies for cancer vaccine adjuvant development.
    Zhang X; Yang B; Ni Q; Chen X
    Chem Soc Rev; 2023 May; 52(9):2886-2910. PubMed ID: 37014050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperbranched Polymer-Based Vaccines for Cancer Immunotherapy.
    Wang Z; Guo Y; Shen M; Wang Y; Shi X
    Macromol Biosci; 2023 Nov; 23(11):e2300188. PubMed ID: 37300444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smart vaccine delivery based on microneedle arrays decorated with ultra-pH-responsive copolymers for cancer immunotherapy.
    Duong HTT; Yin Y; Thambi T; Nguyen TL; Giang Phan VH; Lee MS; Lee JE; Kim J; Jeong JH; Lee DS
    Biomaterials; 2018 Dec; 185():13-24. PubMed ID: 30216806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
    Jin Z; Gao S; Cui X; Sun D; Zhao K
    Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mannan-decorated pathogen-like polymeric nanoparticles as nanovaccine carriers for eliciting superior anticancer immunity.
    Xu Y; Ma S; Zhao J; Chen H; Si X; Huang Z; Yu Z; Song W; Tang Z; Chen X
    Biomaterials; 2022 May; 284():121489. PubMed ID: 35364489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aliphatic Polyester-Based Materials for Enhanced Cancer Immunotherapy.
    Chin AL; Wang X; Tong R
    Macromol Biosci; 2021 Jul; 21(7):e2100087. PubMed ID: 33909344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 16. Gold nanoparticle mediated cancer immunotherapy.
    Almeida JP; Figueroa ER; Drezek RA
    Nanomedicine; 2014 Apr; 10(3):503-14. PubMed ID: 24103304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches.
    Davodabadi F; Sarhadi M; Arabpour J; Sargazi S; Rahdar A; Díez-Pascual AM
    J Control Release; 2022 Sep; 349():844-875. PubMed ID: 35908621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses.
    Yin Q; Wang Y; Xiang Y; Xu F
    Hum Vaccin Immunother; 2022 Nov; 18(6):2119020. PubMed ID: 36170662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid- and Polymer-Based Nanocarrier Platforms for Cancer Vaccine Delivery.
    Sunoqrot S; Abdel Gaber SA; Abujaber R; Al-Majawleh M; Talhouni S
    ACS Appl Bio Mater; 2024 Aug; 7(8):4998-5019. PubMed ID: 38236081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of cancer immunotherapy: DNA vaccines leading the way.
    Pandya A; Shah Y; Kothari N; Postwala H; Shah A; Parekh P; Chorawala MR
    Med Oncol; 2023 Jun; 40(7):200. PubMed ID: 37294501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.